Prelude Capital Management’s Psychemedics Corporation PMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-1,694
Closed -$16K 2141
2019
Q4
$16K Sell
1,694
-1,400
-45% -$12.9K ﹤0.01% 1634
2019
Q3
$28K Sell
3,094
-2,297
-43% -$19.5K ﹤0.01% 1329
2019
Q2
$54K Buy
5,391
+1,617
+43% +$18.4K ﹤0.01% 1095
2019
Q1
$53K Buy
3,774
+1,750
+86% +$30.1K ﹤0.01% 1109
2018
Q4
$32K Buy
2,024
+903
+81% +$15.6K ﹤0.01% 1190
2018
Q3
$21K Sell
1,121
-333
-23% -$6.63K ﹤0.01% 1308
2018
Q2
$28K Sell
1,454
-650
-31% -$13.2K ﹤0.01% 1278
2018
Q1
$45K Sell
2,104
-2,000
-49% -$41.5K ﹤0.01% 1119
2017
Q4
$84K Sell
4,104
-172
-4% -$3.19K 0.01% 829
2017
Q3
$79K Buy
4,276
+672
+19% +$14.8K 0.01% 957
2017
Q2
$90K Sell
3,604
-200
-5% -$4.2K 0.01% 812
2017
Q1
$76K Buy
3,804
+2,330
+158% +$51.1K 0.01% 875
2016
Q4
$36K Buy
1,474
+974
+195% +$21.8K ﹤0.01% 1159
2016
Q3
$10K Buy
+500
New +$9.27K ﹤0.01% 1434

Other funds holding PMD

Prelude Capital Management's PMD Position: Q1 2020 in Review

Prelude Capital Management sold out of Psychemedics Corporation (PMD) in Q1 2020, closing a stake of 1,694 shares — an estimated $16K sold.

Prelude Capital Management first reported a position in PMD in Q3 2016 and held it in 14 quarters. The position peaked at $90K in Q2 2017. 37 funds tracked by Wall St. Rank hold PMD as of Q1 2020.

  • Prelude Capital Management reported no remaining Psychemedics Corporation position as of Q1 2020 after selling out during the quarter.
  • Prelude Capital Management sold 1,694 Psychemedics Corporation shares in Q1 2020, an estimated $16K.
  • Prelude Capital Management first reported a position in Psychemedics Corporation in Q3 2016 and held it in 14 quarters.
  • Prelude Capital Management's Psychemedics Corporation position peaked at $90K in Q2 2017.
  • 37 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q1 2020.

Based on Prelude Capital Management's 13F filing for Q1 2020, filed 15 May 2020.